Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
FDA proposes use of sunscreen ingredient popular in other countries - 2Mexico says a third of 130,000 missing people might be alive, fueling criticism from families
- 3Accor signs agreement to transform El Gouna resort as Sofitel
- 4Vote In favor of Your Favored IT Administration
- 5Robyn returns to music with 'Dopamine,' her 1st single in 7 years: 'Came to save music once again'
- Pleasant Cycle Courses All over the Planet
- NASA loses contact with its Maven spacecraft orbiting Mars for the past decade
- Manual for 6 famous sorts of cheddar
- Transform the daily grind to make life more interesting – a philosopher shares 3 strategies to help you attain the good life
- Figure out How to Improve Your Stream Voyage with Remarkable Trips and Exercises
- We may have one thing in common with jellyfish, new research finds
- Kansas school officials report high student illness, dismiss early
- Deadly heat worldwide prompts $300 million for climate health research at COP30
- 'Euphoria' Season 3 trailer includes Eric Dane's final appearance, Jacob Elordi and Sydney Sweeney at the altar and Zendaya's 'Breaking Bad' era
